Remedent Confirms the Filing of Its 10-K Report for the Fiscal Year Ending March 31, 2015 and Its Return to Profitability

GHENT, BELGIUM--(Marketwired - Jul 1, 2015) - Remedent, Inc. (OTCBB: REMI), an international company specializing in research, development, and manufacturing of oral care and cosmetic dentistry products, announces the filing of its 10-K report for the fiscal year ending March 31, 2015.

Remedent is completing its turnaround. Net sales for the fiscal year ending March 31, 2015 were up by 39.5% compared to net sales for the year ending March 31, 2014; our second profitable year in a row.

Where profitability for the fiscal year ending March 31, 2014 was achieved by a capital transaction, the fiscal year ending March 31, 2015 is profitable on an operational level. As a result, our auditors have agreed to the removing of the going concern statement.

The highlights of the 2015 fiscal year include the successful launch of Smile Me, our Design and Communication software suite, the successful incorporation of our Implants division and our partnership with Vitaldent Spain and the full repayment of our Fortis Credit Line.

Additionally, Remedent will be embarking on a renewed marketing program launching our newly developed 3D Cosmetic Software, which we have been working on over the past years.

This effort will allow us to increase both revenues and earnings and further improve our balance sheet.

About Remedent:

Remedent Inc. creates state-of-the-art dental technologies and marketing concepts. Famous brands are GlamSmile, Remecure, Smile Me and River 8. Headquartered in Belgium, Remedent Inc. manufactures, markets and distributes its products and concepts to more than 25 countries worldwide. Remedent Inc. is publicly listed and focuses on B2B, delivering products to the dental professional, as well as B2C approaches, helping consumers to obtain their dream smile through its Smile Consultancy Concept.

Statement under the Private Securities Litigation Reform Act of 1995
Statements in this press release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Remedent's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," "projects," "project," to be uncertain and forward-looking. Actual results could differ materially because of factors such as Remedent's ability to achieve the synergies and value creation contemplated by the proposed transaction. For further information regarding risks and uncertainties associated with Remedent's business, please refer to the risk factors described in Remedent's filings with the Securities and Exchange Commission, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q.